Johnson & Johnson - 54 Year Stock Price History | JNJ

Historical daily share price chart and data for Johnson & Johnson since 1970 adjusted for splits and dividends. The latest closing stock price for Johnson & Johnson as of November 19, 2024 is 153.00.
  • The all-time high Johnson & Johnson stock closing price was 173.03 on April 25, 2022.
  • The Johnson & Johnson 52-week high stock price is 168.85, which is 10.4% above the current share price.
  • The Johnson & Johnson 52-week low stock price is 143.13, which is 6.5% below the current share price.
  • The average Johnson & Johnson stock price for the last 52 weeks is 156.25.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Johnson & Johnson Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2024 154.7843 156.2831 167.3800 142.1935 153.0000 -0.08%
2023 154.1798 169.0029 170.9567 141.1240 153.1275 -8.60%
2022 161.4853 158.5414 173.0304 147.1051 167.5423 5.97%
2021 150.9818 141.0724 163.7992 138.8414 158.1070 11.45%
2020 129.6185 128.0659 141.8656 98.1429 141.8656 10.85%
2019 117.2338 109.8277 128.4782 108.0825 127.9782 15.35%
2018 112.7947 116.5416 127.0992 101.3239 110.9453 -5.14%
2017 107.2495 94.5232 119.6052 91.1940 116.9518 24.40%
2016 91.4542 79.7409 100.9459 75.9872 94.0092 15.32%
2015 77.9765 80.5469 83.5264 71.4802 81.5186 1.16%
2014 76.6643 68.2597 83.6294 64.9528 80.5854 17.34%
2013 63.3900 51.5578 71.7090 51.4850 68.6796 34.62%
2012 47.8373 46.2460 52.3217 44.1744 51.0192 10.83%
2011 43.7903 42.5487 46.8234 39.4074 46.0354 9.89%
2010 41.3280 42.3136 43.5285 37.9328 41.8917 -0.58%
2009 37.2056 38.3861 42.4968 29.7419 42.1370 11.28%
2008 40.4787 40.5703 45.3513 35.0190 37.8671 -7.77%
2007 38.8677 39.8542 42.1030 36.2234 41.0566 3.61%
2006 36.9000 36.1378 41.2400 33.3056 39.6262 12.44%
2005 37.5446 36.1660 40.0741 35.2055 35.2406 -3.36%
2004 31.8392 29.1332 36.6605 28.0378 36.4650 25.17%
2003 29.3963 30.6602 32.6409 27.3549 29.1332 -2.11%
2002 31.7154 32.0893 35.9136 23.0264 29.7625 -7.88%
2001 28.2157 27.5118 33.3302 22.5308 32.3080 13.97%
2000 23.9642 24.5746 28.3480 18.3257 28.3480 14.04%
1999 24.9326 21.7896 28.2825 20.2902 24.8571 12.46%
1998 19.6514 16.9228 23.4523 16.6471 22.1032 28.99%
1997 15.4123 12.7587 17.4118 12.7587 17.1361 34.31%
1996 12.3546 10.6445 13.7845 10.6445 12.7587 18.11%
1995 8.6262 6.7569 11.5605 6.6639 10.8024 59.14%
1994 5.6677 5.4753 6.8970 4.4746 6.7879 25.00%
1993 5.0197 5.8451 5.8451 4.2853 5.4305 -8.93%
1992 5.7755 6.5091 6.7486 5.0454 5.9632 -10.19%
1991 5.1571 3.9901 6.6975 3.7404 6.6395 62.34%
1990 3.5475 3.3426 4.1408 2.9027 4.0898 23.38%
1989 2.7654 2.2830 3.3147 2.2830 3.3147 42.64%
1988 2.1835 2.0808 2.3910 1.8742 2.3239 16.52%
1987 2.2793 1.7687 2.7717 1.7088 1.9945 15.79%
1986 1.6560 1.3328 1.9293 1.2267 1.7225 27.42%
1985 1.1292 0.8896 1.4065 0.8771 1.3518 49.85%
1984 0.8408 0.9862 1.0224 0.6930 0.9021 -8.53%
1983 1.0882 1.1665 1.2055 0.9469 0.9862 -15.66%
1982 0.9518 0.8424 1.2019 0.7520 1.1693 36.94%
1981 0.7757 0.7465 0.8738 0.6514 0.8539 14.54%
1980 0.5854 0.5579 0.7474 0.4867 0.7455 29.40%
1979 0.5169 0.5250 0.5815 0.4673 0.5761 10.49%
1978 0.5370 0.5187 0.6239 0.4584 0.5214 -1.77%
1977 0.4818 0.5294 0.5308 0.4267 0.5308 0.42%
1976 0.5815 0.6033 0.6443 0.4879 0.5286 -12.02%
1975 0.5929 0.5505 0.6598 0.4891 0.6008 12.01%
1974 0.6507 0.7354 0.7846 0.4970 0.5364 -27.71%
1973 0.7805 0.8418 0.8549 0.6877 0.7420 -13.21%
1972 0.7713 0.6380 0.8649 0.6192 0.8549 32.98%
1971 0.5543 0.3717 0.6453 0.3717 0.6429 73.71%
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $368.366B $85.159B
Johnson & Johnson's biggest strength is its diversified business model. It operates through pharmaceuticals, medical devices and consumer products divisions. Its diversification helps it to withstand economic cycles more effectively. J&J has one of the largest research and development (R&D) budget among pharma companies. J&J's worldwide business is divided into three segments: Pharmaceutical, Medical Devices and Consumer. The company has several drugs covering a broad range of areas such as neuroscience, cardiovascular & metabolism, immunology, oncology, pulmonary hypertension and infectious diseases and vaccines. The Medical Devices Segment offers products in the orthopedics, surgery, interventional solutions and vision markets. The Consumer Segment segment includes a broad range of products covering the areas of baby care, beauty/skin health, oral care, wound care and womens' health care, as well as over-the-counter (OTC) pharmaceutical products.
Stock Name Country Market Cap PE Ratio
Eli Lilly (LLY) United States $692.744B 71.75
Novo Nordisk (NVO) Denmark $460.555B 33.21
AbbVie (ABBV) United States $294.353B 15.49
Merck (MRK) United States $244.211B 16.23
Novartis AG (NVS) Switzerland $211.084B 14.03
AstraZeneca (AZN) United Kingdom $197.819B 16.83
Pfizer (PFE) United States $142.241B 9.73
Sanofi (SNY) $121.816B 11.03
Innoviva (INVA) United States $1.195B 9.94